A
AETHLON MEDICAL INC
NASDAQ: AEMD (Aethlon Medical, Inc.)
Last update: yesterday, 12:49AM1.25
-0.69 (-35.57%)
| Previous Close | 1.94 |
| Open | 1.45 |
| Volume | 963,306 |
| Avg. Volume (3M) | 96,338 |
| Market Cap | 2,513,400 |
| Price / Sales | 2.37 |
| Price / Book | 0.750 |
| 52 Weeks Range | |
| Earnings Date | 13 Aug 2025 |
| Diluted EPS (TTM) | -12.16 |
| Total Debt/Equity (MRQ) | 16.72% |
| Current Ratio (MRQ) | 2.80 |
| Operating Cash Flow (TTM) | -8.54 M |
| Levered Free Cash Flow (TTM) | -5.54 M |
| Return on Assets (TTM) | -72.47% |
| Return on Equity (TTM) | -160.04% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Bearish | |
| Stock | Aethlon Medical, Inc. | Mixed | Bearish |
AIStockmoo Score
-0.4
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.38 |
|
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 4.51% |
| % Held by Institutions | 21.03% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |